HOME >> MEDICINE >> NEWS
UCLA studies experimental cancer drug

Men with high-risk prostate cancer who are candidates for surgery are being sought to test a molecularly targeted experimental drug that may interrupt the signal that is driving their cancer and keep the disease from recurring.

The early-phase clinical trial is based on basic research discoveries made in Jonsson Cancer Center laboratories. UCLA researchers have successfully tested the drug in laboratory and animal models. They hope to translate that benefit into patients in the clinic, said Dr. Charles Sawyers, co-principal investigator for the study and the Jonsson Cancer Center scientist whose basic research resulted in the clinical trial.

UCLA laboratory studies have shown that some patients with prostate cancer have lost PTEN, a tumor-suppressor gene. In some patients who have lost PTEN, a gene called mTOR located downstream in the cell-signaling pathway gets turned on and may be driving the cancer. Sawyers, along with co-principal investigator Dr. Robert Reiter, will test a drug called CCI779, which they believe targets mTOR.

"We discovered that tumors missing PTEN seem to be very responsive to CCI779, and it's very clear at a molecular biology level why," Sawyers said. "When you've lost PTEN, mTOR activity gets turned up and tumors become dependent on it for their growth. So a drug that inhibits mTOR should impact the tumor cells but have no effect on the normal cells."

Armed with his laboratory discoveries, Sawyers proposed the prostate cancer study to Wyeth Pharmaceuticals, and the clinical trial was designed. UCLA's Jonsson Cancer Center is the only West Coast site offering this study. Other sites participating include MD Anderson Cancer Center in Texas and Fox Chase Cancer Center in Philadelphia, Sawyers said.

Because CCI779 targets only what is broken in the cancer cell, it is expected to cause very few side effects, Sawyers said.

UCLA researchers are seeking study volunteers with newly diagnosed prostate ca
'"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
4-Dec-2003


Page: 1 2

Related medicine news :

1. New studies suggest airborne SARS transmission is possible
2. New studies show mixed results on epilepsy drugs and birth defects
3. Brain imaging studies investigate pain reduction by hypnosis
4. Impact of scientific advances on drug studies and membrane research to be explored
5. Two studies find evidence that sunlight may have beneficial influence on cancer
6. More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine
7. Animal studies show stem cells might make biological pacemaker
8. Infants, children prefer sounds over pictures and only slowly become visually oriented, studies find
9. New studies on Ritalin and Alzheimers Disease highlight ACNP Annual Meeting
10. Gender and sex hormones affect the brains pain response and more, according to new studies
11. Analysis of tamoxifen studies reveals slight increase of stroke risk

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCLA studies experimental cancer drug

(Date:3/31/2015)... 2015 NYC based chiropractor Dr. Steven Shoshany, ... He is proud to offer an improved and expanded use ... was able to offer percussive soft tissue treatment ... also able to offer full body Active Release Technique treatment ... Tape, he is now also able to offer percussive therapy ...
(Date:3/31/2015)... 31, 2015 In addition to their corporate ... the Burn Institute, Bill Howe Plumbing is proud to sponsor ... their own employees. One example of an employee led ... Mesa, Ca. The San Diego plumbing company has ... their field supervisor, an accomplished musician and plumber. , This ...
(Date:3/31/2015)... 2015 A new study by Health eCareers ... rank employee turnover as their greatest staffing concern this year ... the battle – once you have them, you need to ... trends in healthcare recruiting blog series , which profiles ... Turnover in hospitals has high numbers and results in high ...
(Date:3/31/2015)... Wisconsin (PRWEB) March 31, 2015 The legendary ... 5 to October 2 in North America, and dates for ... areas. The group will perform many great hits during upcoming ... for March 30 on Hollywood Boulevard that will air on ... television appearance in the U.S. featuring David Lee Roth. , ...
(Date:3/30/2015)... 31, 2015 A new legal ... and family members who may have been prescribed Zofran, ... morning sickness. The site was created in response to ... in C.A. No. 11-10398-RWZ, filed with the United States ... reports that this case alleged that GlaxoSmithKline gave ...
Breaking Medicine News(10 mins):Health News:NYC Chiropractor Dr Steven Shoshany Expands Percussive Massage Offering 2Health News:NYC Chiropractor Dr Steven Shoshany Expands Percussive Massage Offering 3Health News:Bill Howe Plumbing, Inc. Sponsors Spring Harp Fest for the Sixth Year 2Health News:Bill Howe Plumbing, Inc. Sponsors Spring Harp Fest for the Sixth Year 3Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 3Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 4Health News:Van Halen Presale Tickets: QueenBeeTickets.com Kicks Off Van Halen Ticket Sales with Reduced Prices on Seats for the 2015 Concert Tour During This Week's Presales 2Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2
(Date:3/30/2015)... Mar. 26, 2015 Research and Markets ... of the "Computer Aided Detection (CAD) - ... offering. Annual estimates and forecasts are ... a six-year historic analysis is provided for these ... primary and secondary research. Company profiles are primarily ...
(Date:3/30/2015)... 30, 2015  Uroplasty, Inc. (NASDAQ: UPI ) ... have voted at the special meeting of each ... announced agreement and plan of merger between the ... the outcome of today,s special meetings, and I ... approving the merger agreement," said Rob Kill ...
(Date:3/30/2015)... 2015  Caris Life Sciences® today announced the presentation ... may have potentially significant benefit in a select subset ... highlighted today in an oral presentation in a Plenary ... Annual Meeting on Women,s Cancer in Chicago, ... of four presented at the annual meeting that utilizes ...
Breaking Medicine Technology:Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 2Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 3Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 4Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4
Cached News: